This is a new medication looking at a potential treatment for people with Parkinson’s disease and other brain disorders with similar symptoms of motor (movement) and neurological deficits, like loss of movement and balance, slow movements or stiffness and involuntary shaking.
Eligible participants must be moderate to heavy smoker in the last 6 months (approx. 1 pack a day or approx. 39 cigarettes per week), not be taking any medication and must be available to stay at our unit for the following schedule:
4 days/nights inpatient stay
1 outpatient visits
Contact us now to register your interest and to find out the reimbursement amount – 1800 243 733.
Or email the team at firstname.lastname@example.org and quote “Smoker Study”.